Desager JP - Search Results

1

Effects of simvastatin and pravastatin on 6 beta-hydroxycortisol excretion, a potential marker of cytochrome P-450 3A.

Horsmans Y, Desager JP, van den Berge V, Abrassart M, Harvengt C. Horsmans Y, et al. Among authors: desager jp. Pharmacol Res. 1993 Oct-Nov;28(3):243-8. doi: 10.1006/phrs.1993.1127. Pharmacol Res. 1993. PMID: 8108314

2

Absence of CYP3A genetic polymorphism assessed by urinary excretion of 6 beta-hydroxycortisol in 102 healthy subjects on rifampicin.

Horsmans Y, Desager JP, Harvengt C. Horsmans Y, et al. Among authors: desager jp. Pharmacol Toxicol. 1992 Oct;71(4):258-61. doi: 10.1111/j.1600-0773.1992.tb00980.x. Pharmacol Toxicol. 1992. PMID: 1454750

3

Effects of combined bezafibrate-simvastatin appraised in healthy subjects.

Horsmans Y, Desager JP, Harvengt C. Horsmans Y, et al. Among authors: desager jp. J Clin Pharmacol. 1992 May;32(5):422-6. doi: 10.1002/j.1552-4604.1992.tb03857.x. J Clin Pharmacol. 1992. PMID: 1587959 Clinical Trial.

4

Lack of effect by nifedipine on hepatic mixed function oxidase in man.

Horsmans Y, Desager JP, Pauwels S, Harvengt C. Horsmans Y, et al. Among authors: desager jp. Fundam Clin Pharmacol. 1991;5(3):193-201. doi: 10.1111/j.1472-8206.1991.tb00711.x. Fundam Clin Pharmacol. 1991. PMID: 1937348

5

Biochemical changes and morphological alterations of the liver in guinea-pigs after administration of simvastatin (HMG CoA reductase-inhibitor).

Horsmans Y, Desager JP, Harvengt C. Horsmans Y, et al. Among authors: desager jp. Pharmacol Toxicol. 1990 Oct;67(4):336-9. doi: 10.1111/j.1600-0773.1990.tb00840.x. Pharmacol Toxicol. 1990. PMID: 2077527

6

Clinical pharmacokinetics of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors.

Desager JP, Horsmans Y. Desager JP, et al. Clin Pharmacokinet. 1996 Nov;31(5):348-71. doi: 10.2165/00003088-199631050-00003. Clin Pharmacokinet. 1996. PMID: 9118584 Review.

7

Lecithin: cholesterol acyltransferase activity in familial hypercholesterolemia treated with simvastatin and simvastatin plus low-dose colestipol.

Desager JP, Horsmans Y, Harvengt C. Desager JP, et al. J Clin Pharmacol. 1991 Jun;31(6):537-42. doi: 10.1002/j.1552-4604.1991.tb03734.x. J Clin Pharmacol. 1991. PMID: 1880219

8

[Sensitivity and specificity of the determination of urinary catecholamines and their acid metabolites in the diagnosis of neuroblastoma in children].

Horsmans Y, Desager JP, Harvengt C. Horsmans Y, et al. Among authors: desager jp. Bull Cancer. 1990;77(10):985-9. Bull Cancer. 1990. PMID: 2249018 French.

9

Influence of rifampicin, phenobarbital and cimetidine on mixed function monooxygenase in extensive and poor metabolizers of debrisoquine.

Leclercq V, Desager JP, Horsmans Y, Van Nieuwenhuyze Y, Harvengt C. Leclercq V, et al. Among authors: desager jp. Int J Clin Pharmacol Ther Toxicol. 1989 Dec;27(12):593-8. Int J Clin Pharmacol Ther Toxicol. 1989. PMID: 2613393

10

Changes in plasma activities of lipolytic enzymes and lipids of normolipidemic subjects given phenobarbital, a strong microsomal inducer, alone or in combination with fenofibrate.

Heller FR, Desager JP, Harvengt C. Heller FR, et al. Among authors: desager jp. Int J Clin Pharmacol Ther Toxicol. 1988 Mar;26(3):138-42. Int J Clin Pharmacol Ther Toxicol. 1988. PMID: 3410596

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

115 results

Search Page

Filters